432 related articles for article (PubMed ID: 18396390)
1. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation.
Fahmy RH; Kassem MA
Eur J Pharm Biopharm; 2008 Aug; 69(3):993-1003. PubMed ID: 18396390
[TBL] [Abstract][Full Text] [Related]
2. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.
Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M
J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594
[TBL] [Abstract][Full Text] [Related]
3. In vitro release evaluation of hydrocortisone liquisolid tablets.
Spireas S; Sadu S; Grover R
J Pharm Sci; 1998 Jul; 87(7):867-72. PubMed ID: 9649356
[TBL] [Abstract][Full Text] [Related]
4. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
[TBL] [Abstract][Full Text] [Related]
5. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.
Javadzadeh Y; Musaalrezaei L; Nokhodchi A
Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643
[TBL] [Abstract][Full Text] [Related]
6. Formulation factors affecting the release of ezetimibe from different liquisolid compacts.
Khanfar M; Sheikh Salem M; Hawari R
Pharm Dev Technol; 2013; 18(2):417-27. PubMed ID: 22530561
[TBL] [Abstract][Full Text] [Related]
7. Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles.
Elkordy AA; Essa EA; Dhuppad S; Jammigumpula P
Int J Pharm; 2012 Sep; 434(1-2):122-32. PubMed ID: 22677418
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of dissolution rate of piroxicam using liquisolid compacts.
Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M; Nokhodchi A
Farmaco; 2005 Apr; 60(4):361-5. PubMed ID: 15848213
[TBL] [Abstract][Full Text] [Related]
9. Improvement of dissolution properties of Carbamazepine through application of the liquisolid tablet technique.
Tayel SA; Soliman II; Louis D
Eur J Pharm Biopharm; 2008 May; 69(1):342-7. PubMed ID: 17949959
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability and biological activity of liquisolid compact formula of repaglinide and its effect on glucose tolerance in rabbits.
El-Houssieny BM; Wahman L; Arafa NM
Biosci Trends; 2010 Feb; 4(1):17-24. PubMed ID: 20305340
[TBL] [Abstract][Full Text] [Related]
11. Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties.
Gong W; Wang Y; Sun L; Yang J; Shan L; Yang M; Gao C
Curr Drug Deliv; 2016; 13(3):452-61. PubMed ID: 26882116
[TBL] [Abstract][Full Text] [Related]
12. Upgrading of dissolution and anti-hypertensive effect of Carvedilol via two combined approaches: self-emulsification and liquisolid techniques.
Ibrahim TM; Abdallah MH; El-Megrab NA; El-Nahas HM
Drug Dev Ind Pharm; 2018 Jun; 44(6):873-885. PubMed ID: 29254384
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine.
Mady FM; Abou-Taleb AE; Khaled KA; Yamasaki K; Iohara D; Taguchi K; Anraku M; Hirayama F; Uekama K; Otagiri M
Int J Pharm; 2010 Sep; 397(1-2):1-8. PubMed ID: 20600734
[TBL] [Abstract][Full Text] [Related]
14. Spironolactone release from liquisolid formulations prepared with Capryol™ 90, Solutol® HS-15 and Kollicoat® SR 30 D as non-volatile liquid vehicles.
Elkordy AA; Tan XN; Essa EA
Eur J Pharm Biopharm; 2013 Feb; 83(2):203-23. PubMed ID: 22960707
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of griseofulvin release from liquisolid compacts.
Hentzschel CM; Alnaief M; Smirnova I; Sakmann A; Leopold CS
Eur J Pharm Biopharm; 2012 Jan; 80(1):130-5. PubMed ID: 21846502
[TBL] [Abstract][Full Text] [Related]
16. Effect of Ceolus KG-802 on the dissolution rate of fenofibrate liquisolid tablets: Preformulation and formulation development studies.
Karmarkar AB
Drug Discov Ther; 2010 Dec; 4(6):493-8. PubMed ID: 22491315
[TBL] [Abstract][Full Text] [Related]
17. Physico-chemical comparison of famotidine tablets prepared via dry granulation and direct compression techniques.
Baseer A; Hassan F; Hassan SF; Jabeen S; Israr F; Murtaza G; Haque N
Pak J Pharm Sci; 2013 May; 26(3):439-43. PubMed ID: 23625414
[TBL] [Abstract][Full Text] [Related]
18. Optimization and validation of a dissolution test for famotidine tablets using flow injection analysis.
Tzanavaras PD; Verdoukas A; Balloma T
J Pharm Biomed Anal; 2006 May; 41(2):437-41. PubMed ID: 16413732
[TBL] [Abstract][Full Text] [Related]
19. Development of modified dosage form for enhancement of dissolution rate through amalgamation of solid dispersion and cube sugar or sintering technology using famotidine as a model drug.
Gupta V; Gupta M; Madan AK
PDA J Pharm Sci Technol; 2009; 63(1):58-70. PubMed ID: 19455942
[TBL] [Abstract][Full Text] [Related]
20. Effects of liquisolid formulations on dissolution of naproxen.
Tiong N; Elkordy AA
Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
